HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)

Clinical trial NCT07594340 · RECRUITING

Trial details

NCT number: NCT07594340
Sponsor: Binkui Li
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2026-05-15
Primary completion: 2030-05-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.